# A Clinical Study to Evaluate the Safety and Immunogenicity of Inactivated Poliomyelitis Vaccine in Healthy Infants

> **NCT03169725** · PHASE2,PHASE3 · COMPLETED · sponsor: **LG Chem** · enrollment: 1417 (actual)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** Inactivated Poliomyelitis Vaccine (Sabin strain)
- **BIOLOGICAL:** Inactivated Poliomyelitis Vaccine (Salk strain)

## Key facts

- **NCT ID:** NCT03169725
- **Lead sponsor:** LG Chem
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-31
- **Primary completion:** 2019-01-18
- **Final completion:** 2019-06-14
- **Target enrollment:** 1417 (ACTUAL)
- **Last updated:** 2019-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03169725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03169725, "A Clinical Study to Evaluate the Safety and Immunogenicity of Inactivated Poliomyelitis Vaccine in Healthy Infants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03169725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*